We welcome Honorary Professor Manish Chand as Chief Medical Officerat at CarpoNovum

Honorary Professor Manish Chand, University College London and Apollo Hospitals, has accepted the position as Chief Medical Officer for CarpoNovum AB. As a highly experienced specialist surgeon and global key opinion leader in the fields of colorectal and minimally-invasive surgery, we believe that he is an excellent fit for our company.

Professor Chand is well cited in the medical literature for his research and has published several key articles including bringing new technologies into clinical practice (top 2% of global academics). He is an active member of the surgical community being frequently invited as faculty member and tutor at congresses and is very well connected with both academia and medical device companies. In addition, he is a senior member of the Technology Committees for The American College of Surgeons, European Association of Endoscopic Surgeons and American Society of Colorectal Surgeons.

We welcome Prof. Anna Martling to our Clinical Advisory Board at CarpoNovum

Photo from Karolinska Institutet.

Anna Martling is a Professor of Surgery at Karolinska Institutet, Stockholm, Sweden. She defended her thesis on rectal cancer in 2003, became a board certified surgeon in 2004 and an associate professor of surgery in 2009. In 2014 Martling became full professor of surgery. Since 2019 she holds the position as Dean at Karolinska Institutet, Stockholm. She is considered to be a world leading expert in her field and is a frequent lecturer in Sweden and abroad. Professor Martling is Honorary Fellow of Royal College of Surgeon of England, (FRCS), American Colleges of Surgeons (FACS) and American Society of Colorectal Surgeons (FASCRS). Professor Martling is chairman of the Swedish Colorectal Cancer Study Group, which is a national research network for colorectal cancer in Sweden. Professor Martling has received numerous awards for her research within the colorectal field and in 2023 she was appointed honorary member of the European Society of Coloproctology (ESCP) which is awarded to individuals who have made an outstanding contribution to the field of coloproctology.

CarpoNovum has a new CEO

As of September 1st, Otto Drakenberg, the current Chairman of CarpoNovum, will also assume the role of CEO of the company. This move will streamline governance and fully align the organization behind a strengthened and highly skilled clinical team, committed to delivering our clinical strategy.

Current CEO Pär-Ola Larsson will take on the role of Vice CEO as of 1 September until he leaves for an assignment in another medical device company during the fall. We wish him good luck in his future endeavours and thank him for his contribution.